Influence of Hormonal Profile on Resting Metabolic Rate in Normal, Overweight and Obese Individuals. 2015

Thomas G Wright, and Brian Dawson, and Geoffrey Jalleh, and Kym J Guelfi

OBJECTIVE To investigate whether blood thyroid stimulating hormone (TSH), cortisol, insulin and glucose concentrations (plus glucose:insulin ratio; GIR) could improve the accuracy of resting metabolic rate (RMR) prediction in normal, overweight and obese persons. METHODS Predictive equations were developed and compared against indirect calorimetry measures for RMR in 217 weight-control clinic participants (n = 128 males and n = 89 females: ∼24% normal weight, ∼39% overweight and ∼37% obese). RESULTS Using the common accuracy criteria of the proportion of predicted RMR within ±10% of measured RMR, our equations (using age, height, weight and gender, plus the blood factors, both independently and in combination) were accurate ∼36-44% of the time, for the whole sample, and when separated by gender and weight class. Specifically, the addition of the blood hormone and glucose concentrations improved the accuracy of predicted RMR by only 1-8% (NS). CONCLUSIONS Including blood TSH, cortisol, insulin, glucose and GIR into RMR prediction equations did not significantly improve estimation accuracy, which in any case only met a criterion of ±10% of the measured RMR ∼40% of the time. Further work to refine the prediction of RMR is still needed, and at present, direct measurements should be made wherever possible.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Thomas G Wright, and Brian Dawson, and Geoffrey Jalleh, and Kym J Guelfi
July 2005, Obesity research,
Thomas G Wright, and Brian Dawson, and Geoffrey Jalleh, and Kym J Guelfi
January 1979, International journal of obesity,
Thomas G Wright, and Brian Dawson, and Geoffrey Jalleh, and Kym J Guelfi
April 2016, European journal of nutrition,
Thomas G Wright, and Brian Dawson, and Geoffrey Jalleh, and Kym J Guelfi
June 2017, Journal of endocrinological investigation,
Thomas G Wright, and Brian Dawson, and Geoffrey Jalleh, and Kym J Guelfi
May 1980, The American journal of clinical nutrition,
Thomas G Wright, and Brian Dawson, and Geoffrey Jalleh, and Kym J Guelfi
August 2023, Metabolites,
Thomas G Wright, and Brian Dawson, and Geoffrey Jalleh, and Kym J Guelfi
January 1986, International journal of obesity,
Thomas G Wright, and Brian Dawson, and Geoffrey Jalleh, and Kym J Guelfi
January 2021, Obesity research & clinical practice,
Thomas G Wright, and Brian Dawson, and Geoffrey Jalleh, and Kym J Guelfi
January 2016, Obesity facts,
Thomas G Wright, and Brian Dawson, and Geoffrey Jalleh, and Kym J Guelfi
December 2013, Clinical journal of the American Society of Nephrology : CJASN,
Copied contents to your clipboard!